- Darmiyan CEO Padideh Kamali-Zare achievements are recognized among Top 25 Women in Biotech 2021 according to Healthcare Tech Outlook magazine’s review. Biotech plays a critical role in the well-being of global society, HealthTech Report commented.
- Her digital health company Darmiyan, best known for its AI-Powered BrainSee technology, which earned an FDA Breakthrough designation in May, also secured a finalist spot at UCSF Health Awards recently. Using standard, non-invasive clinical brain MRI, Darmiyan’s BrainSee software can objectively measure brain health, including detecting Alzheimer’s disease at the early prodromal stage, enabling timely medical interventions and care planning.
- Darmiyan CEO Padideh Kamali-Zare rose above hundreds of nominations. Healthcare Tech Outlook used comprehensive analysis of professional achievements and company milestones, positive feedback from colleagues, metrics on industry influence to select her for its illustrious list, topped in 2021 by Samsung Biologics.
Click image above to view full announcement.
Distributed by: Reportable, Inc.